Health Condition 1: O00-O9A- Pregnancy, childbirth and the puerperium
Conditions
Interventions
Intervention1: administration of intravenous infusion of 150 mcg/hr of norepinephrine: Study participants will be randomized into 2 groups. One intervention group receiving an intravenous infusion of
Sponsors
Joydeepa Das
Eligibility
Inclusion criteria
Inclusion criteria: Patients of age group 18 to 45 years undergoing elective caesarean section Patients with American Society of Anaesthesiologists (ASA) physical grade I or II
Exclusion criteria
Exclusion criteria: history of allergy to local anesthetic drug and study drugs local site infection spinal deformity parturients with PET or any hypertensive disorder bleeding disorders cardiac, respiratory diseases, kidney disorders, neurological deficit
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| occurence of hypotensionTimepoint: outcome will be continuosly recorded every 2 mins till 10mins then every 5 mins until the end of surgery and data will be assessed at the end of one year | — |
Secondary
| Measure | Time frame |
|---|---|
| Apgar score, umbilical vein blood gases record, hemodynamic changes, norepinephrine consumption, adverse effectsTimepoint: all outcomes will be continuously recorded every 2 mins till 10 mins and then every 5 mins until the end of surgery | — |
Countries
India
Contacts
Public ContactDr T Hemjit Singh
Regional Institute of Medical Sciences
Outcome results
None listed